Research Interests


image01 Screening for potent anti-tubercular compounds and evaluating their in-vivo efficacy
image01  Primary screening of compounds against Non-tuberculous Mycobacteria (NTM) and revealing their pathology in established animal models
image01  Molecular approaches to unravel novel mycobacterial drug targets